Evaluation of the Prognostic Impact of a Neuro-vascular Examination Associated with Cerebral MRI in the Acute Phase of Infectious Endocarditis (POMPEI)
Status
Conditions
Treatments
Details and patient eligibility
About
Infectious endocarditis (IE) is a serious condition with an annual incidence of 3 to 10 per 100,000 people. Brain infarctions complicate approximately 20-40% of endocarditis.
Brain MRI can detect the presence of recent ischemic lesions and asymptomatic microbleeds. Preoperative brain imaging is part of the recommended assessment in the management of IEs, but the type of imaging and sequences are not codified and the impact of cerebral and vascular imaging findings on the therapeutic decision remains uncertain.
The level of evidence of the recommendations remains low, especially for complicated IEs of stroke. There is very little neurological clinical data on patients with IEs. Similarly, neurologists do not systematically participate in multidisciplinary meetings during the management of an IE. It therefore seems interesting to carry out a neurological cohort of this population and to evaluate what would be the contribution of vascular neurologists in the management of infectious endocarditis.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Adult patients
- Certain infectious endocarditis according to Dukes Criteria
- Signed informed consent
Exclusion criteria
- Hospital admission due to neurovascular emergency
- MRI contraindications
- Pregnant or women of childbearing age who were not using contraception (oral diagnosis),
- Patient without health coverage,
- Patient under legal protection.
Trial design
Primary purpose
Allocation
Interventional model
Masking
110 participants in 1 patient group
Trial contacts and locations
Loading...
Central trial contact
Julia CANTERINI; Elodie ONG, Dr
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal